Name: UMIN ID:
Unique ID issued by UMIN | UMIN000020084 |
---|---|
Receipt number | R000023203 |
Scientific Title | The Usefulness and Hemodynamic Effect of Landiolol Treatment to Control Atrial Tachyarrhythmia in Patients with Heart Failure with Reduced Ejection Fraction in The Acute Phase |
Date of disclosure of the study information | 2015/12/07 |
Last modified on | 2023/06/15 23:58:35 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/12/05 23:30:41 | ||
2 | Update | 2017/07/22 16:38:11 | Key inclusion criteria Key inclusion criteria |
|
3 | Update | 2017/07/22 16:41:07 | Narrative objectives1 Narrative objectives1 Key secondary outcomes Key secondary outcomes |
|
4 | Update | 2018/05/15 13:19:03 | Study type Basic design Randomization Blinding Control No. of arms Purpose of intervention Type of intervention Interventions/Control_1 Interventions/Control_1 |
|
5 | Update | 2018/05/15 13:21:37 | Interventions/Control_1 Interventions/Control_1 |
|
6 | Update | 2019/12/11 13:19:36 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Address Name of primary person or sponsor Institute Organization Organization Category of Funding Organization Organization Organization Address Address Tel Institutions |
|
7 | Update | 2019/12/11 13:31:36 | Date of IRB Anticipated trial start date Last follow-up date |
|
8 | Update | 2019/12/11 13:32:20 | Other related information |
|
9 | Update | 2019/12/11 13:33:22 | Other related information |
|
10 | Update | 2020/09/13 22:33:50 | Recruitment status |
|
11 | Update | 2023/06/15 23:58:35 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |